BPC-157 15mg
BPC-157 is a penta-decapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that was discovered in and isolated from human gastric juice. Animal studies have shown it to accelerate the healing of many different wounds, including muscle, tendon and damaged ligaments. Additionally, BPC 157 has shown to protect organs and aids in the prevention of gastric ulcers. BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohn’s disease. This peptide has been known to exhibit analgesic characteristics. Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues. BPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis together with stimulation of macrophages and fibroblasts infiltration representing a potential therapeutic tool in wound healing management.
BPC-157 5mg
BPC-157, TB-500 10mg (Blend)
BPC-157, TB-500 20mg (Blend)
BPC-157, TB-500, GHK-Cu 30mg (Glow Blend)
BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg
(30mg Total Glow Blend)
Mechanisms and Synergy
-
BPC-157: A stable gastric pentadecapeptide shown to accelerate angiogenesis, fibroblast migration, and epithelial repair via modulation of VEGFR2, FAK-paxillin pathways, and nitric oxide signaling. It enhances tendon, muscle, and intestinal healing in preclinical models.
-
TB-500 (Thymosin Beta-4): A 43-amino acid actin-sequestering peptide that promotes tissue regeneration through cell migration, angiogenesis (via VEGF upregulation), and anti-inflammatory effects. It mobilizes progenitor cells and accelerates repair of myocardium, dermis, and connective tissue.
-
GHK-Cu: A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that stimulates wound healing, collagen synthesis, and hair growth. It modulates gene expression linked to tissue remodeling and exerts antioxidant and anti-inflammatory effects through TGF-β and metalloproteinase regulation.
Synergistic Benefits:
Combined research with BPC-157, TB-500, and GHK-Cu may offer synergistic tissue regeneration and anti-inflammatory benefits by concurrently activating multiple repair pathways:
-
Angiogenesis: TB-500 and BPC-157 both promote VEGF-mediated vascularization, while GHK-Cu enhances endothelial cell proliferation.
-
Cellular migration and matrix remodeling: TB-500 improves actin polymerization and cellular motility; GHK-Cu and BPC-157 stimulate ECM production and fibroblast activity.
-
Anti-inflammatory modulation: All three reduce oxidative stress and cytokine-driven inflammation, potentially improving healing in chronic or complex injuries.
This multifactorial synergy suggests enhanced efficacy in musculoskeletal, dermatological, and post-surgical recovery applications.
BPC-157, TB-500, GHK-Cu 60mg (Glow Blend)
- BPC-157: A stable gastric pentadecapeptide shown to accelerate angiogenesis, fibroblast migration, and epithelial repair via modulation of VEGFR2, FAK-paxillin pathways, and nitric oxide signaling. It enhances tendon, muscle, and intestinal healing in preclinical models.
- TB-500 (Thymosin Beta-4): A 43-amino acid actin-sequestering peptide that promotes tissue regeneration through cell migration, angiogenesis (via VEGF upregulation), and anti-inflammatory effects. It mobilizes progenitor cells and accelerates repair of myocardium, dermis, and connective tissue.
- GHK-Cu: A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that stimulates wound healing, collagen synthesis, and hair growth. It modulates gene expression linked to tissue remodeling and exerts antioxidant and anti-inflammatory effects through TGF-β and metalloproteinase regulation.
- Angiogenesis: TB-500 and BPC-157 both promote VEGF-mediated vascularization, while GHK-Cu enhances endothelial cell proliferation.
- Cellular migration and matrix remodeling: TB-500 improves actin polymerization and cellular motility; GHK-Cu and BPC-157 stimulate ECM production and fibroblast activity.
- Anti-inflammatory modulation: All three reduce oxidative stress and cytokine-driven inflammation, potentially improving healing in chronic or complex injuries.
Bronchogen 20mg (Bioregulator)
Bronchogen is a bioregulatory peptide with tissue-specific effects in the lungs. Research in rat models shows that Bronchogen can decrease inflammation and reestablish health lung tissue states by affecting several DNA transcription pathways. The net effect of Bronchogen in the lungs is to improve the epithelium, increase surfactant production, and reduce inflammation. There is ongoing research looking at the benefit of Bronchogen not just in disease, but in aging as well. It appears that Bronchogen is geroprotective, helping to reverse age-related decline in lung function by reactivating senescent DNA. The peptide may even prove useful in helping to unravel the pathways that protect against cancer development in the lungs.
Cagrilintide 10mg
Cagrilintide is a long-acting analogue of amylin, a naturally occurring peptide that is released in conjunction with insulin. Cagrilintide has shown promise in animal trials as a treatment for obesity and type 2 diabetes. It has been studied for benefits not just in type 2 diabetes, but for liver damage, alcohol-related liver disease, and heart/blood vessel disease. There is some speculation about the role of this peptide in Alzheimer’s disease as well, but no research has been published in that particular sub-domain, yet. Many trials, however, have looked at the combination of cagrilintide and semaglutide in the treatment of obesity and type 2 diabetes. The two proteins appear to work synergistically to provide more robust and more permanent weight loss effects. It is important to note that while preclinical studies suggest promising therapeutic potential, clinical trials in humans are limited. Further research needs to be done to determine the efficacy and safety profiles.
Cardiogen 20mg (Bioregulator)
Cardiogen, is a bioregulator peptide which appears to have potent effects on multiple body tissues including the heart and prostate. Additionally, the peptide may be beneficial in the treatment of certain types of cancer, particularly sarcoma. Currently, the biggest benefits of cardiogen appear to be in the settings of heart attack, hypertension, and chronic heart failure where the peptide not only offers benefits of its own accord, but acts in a synergistic manner with established treatments.
Cartalax 20mg (Bioregulator)
Cartalax is a short bioregulatory peptide with widespread systemic impact due to its effects on fibroblasts. It has been shown to benefit skin and other connective tissues as well as the kidneys. Research shows that Cartalax increases cell proliferation rates and beneficially alters the levels of various cytokines and signaling molecules associated with senescence. Overall, it increases cell health and proliferation while decreasing cell death. Cartalax is thought of as an anti-aging peptide, returning older cells to a more youthful state and prolonging overall tissue health.
Chonluten 20mg (Bioregulator)
Chonluten is a short peptide bioregulator of gene expression. Research has shown it to be most active in lung tissue with secondary levels of activity in the GI tract. It regulates genes related to inflammation and antioxidant activity as well as genes involved in proliferation responses to inflammation. Regulation of pulmonary mucosal function by Chonluten may have important applications in chronic inflammatory diseases of the lung such as asthma and COPD.
